Clinical trial

Lumateperone for Late-Life Depression

NCT07623135

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-09-01

PhasePHASE3

Study timeline

Study start (actual)2026-09-01Date precision: day

Registry last updated2026-09-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Treatment Resistant Depression (TRD)unresolved

Late Life Depression (LLD)unresolved

Depression / Major Depressive Disorderunresolved

Interventions

LumateperoneDRUG · verified · RxNorm: lumateperone

Sponsors & collaborators

Eric Lenzelead sponsor

Intra-Cellular Therapies, Inc.collaborator

Washington University School of Medicinecollaborator

Mapped research locations

St LouisMissouri, United States1 TucsonArizona, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07623135 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.